Pharmaceutical Technology on MSN
FDA rejects Regeneron’s pre-filled Eylea HD syringes amid filling facility woes
Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.
A few things happen when you get a corticosteroid injection at the dermatologist’s office. “We inject it into active inflamed ...
Combining optimized safety and security, Schreiner MediPharm's Cap-Lock plus RFID ensures product integrity while increasing efficiencies via digitalization.
Discover Regeneron’s Q3 2025 earnings: strong Dupixent, Libtayo & EYLEA HD growth, R&D updates, plus key manufacturing and regulatory challenges.
(Reuters) -Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand ...
Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing ...
Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a ...
Innovations in injectable drug packaging are transforming how medications are delivered, combining safety, convenience, and ...
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) approved a single-injection, once-monthly maintenance regimen (200 mg/2 mL) of Omvoh (mirikizumab-mrkz) for ...
Experts blame misinformation and “vaccine fatigue” for declining demand for flu shots. Here's what you should know about flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback